Abstract
Detection of sarcopenia in primary care is a first and essential step in community-dwelling older adults before implementing preventive interventions against the onset of disabling conditions. In fact, leaving this condition undiagnosed and untreated can impact on the individual’s quality of life and function, as well as on healthcare costs. This article summarizes the many instruments today available for promoting an earlier and prompter detection of sarcopenia in primary care, combining insights about its clinical management. Primary care physicians may indeed play a crucial role in the identification of individuals exposed to the risk of sarcopenia or already presenting this condition. To confirm the suspected diagnosis, several possible techniques may be advocated, but it is important that strategies are specifically calibrated to the needs, priorities and resources of the setting where the evaluation is conducted. To tackle sarcopenia, nutritional counselling and physical activity programs are today the two main interventions to be proposed. Multicomponent and personalized exercise programs can (and should) be prescribed by primary care physicians, taking advantage of validated programs ad hoc designed for this purpose (e.g., the Vivifrail protocol). It is possible that, in the next future, new pharmacological treatments may become available for tackling the skeletal muscle decline. These will probably find application in those individuals non-responding to lifestyle interventions.
Similar content being viewed by others
References
Rosenberg I, Roubenoff R. Stalking sarcopenia. Ann Intern Med, 1995;123(9):727–728.
Cao L, Morley JE. Sarcopenia Is Recognized as an Independent Condition by an International Classification of Disease, Tenth Revision, Clinical Modification (ICD-10-CM) Code. J Am Med Dir Assoc, 2016;17(8):675–677. doi:https://doi.org/10.1016/j.jamda.2016.06.001.
Beaudart C, McCloskey E, Bruyère O, et al. Sarcopenia in daily practice: assessment and management. BMC Geriatr, 2016;16(1):170. doi:https://doi.org/10.1186/s12877-016-0349-4.
Calvani R, Miccheli A, Landi F, et al. Current nutritional recommendations and novel dietary strategies to manage sarcopenia. J Frailty Aging, 2013;2(1):16.
Beaudart C, Dawson A, Shaw S, et al. Nutrition and physical activity in the prevention and treatment of sarcopenia: systematic review. Osteoporos Int, 2017;28(6):1817–1833. doi:https://doi.org/10.1007/s00198-017-3980-9.
Marzetti E, Sanna T, Calvani R, Bernabei R, Landi F, Cesari M. Brand New Medicine for an Older Society. J Am Med Dir Assoc, 2016;17(6):558–559. doi:https://doi.org/10.1016/j.jamda.2016.02.024.
Beaudart C, Rizzoli R, Bruyère O, Reginster J, Biver E. Sarcopenia: burden and challenges for public health. Arch Public Health, 2014;72(1):45.
Cesari M, Fielding R, Bénichou O, et al. Pharmacological interventions in frailty and sarcopenia: report by the International Conference on Frailty and Sarcopenia Research task force. J Frailty Aging, 2015;4(3):114–120. doi:https://doi.org/10.14283/jfa.2015.64.
Cruz-Jentoft AJ, Landi F, Schneider SM, et al. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing, 2014;43(6):748–759. doi:https://doi.org/10.1093/ageing/afu115.
Englesbe MJ, Patel SP, He K, et al. Sarcopenia and Mortality after Liver Transplantation. J Am Coll Surg, 2010;211(2):271–278. doi:https://doi.org/10.1016/j.jamcollsurg.2010.03.039.
Tan B, Birdsell L, Martin L, Baracos V, Fearon K. Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer. Clin Cancer Res, 2009;15(22):6973–6979. doi:https://doi.org/10.1158/1078-0432.CCR-09-1525.
Janssen I, Shepard D, Katzmarzyk P, Roubenoff R. The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc, 2004;52(1):80–85. doi:https://doi.org/10.1111/j.1532-5415.2004.52014.x.
Sousa A, Guerra R, Fonseca I, Pichel F, Ferreira S, Amaral T. Financial impact of sarcopenia on hospitalization costs. Eur J Clin Nutr, 2016;70(9):1046–1051.
Janssen I. Skeletal Muscle Cutpoints Associated with Elevated Physical Disability Risk in Older Men and Women. Am J Epidemiol, 2004;159(4):413–421. doi:https://doi.org/10.1093/aje/kwh058.
Dent E, Morley J, Cruz-Jentoft A, et al. International Clinical Practice Guidelines for Sarcopenia (ICFSR): Screening, Diagnosis and Management. J Nutr Health Aging, 2018;22(10):1148–1161.
Malmstrom T, Morley J. SARC-F: a simple questionnaire to rapidly diagnose sarcopenia. J Am Med Dir Assoc, 2013;14(8):531–532. doi:https://doi.org/10.1016/j.jamda.2013.05.018.
Cruz-Jentoft A, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48:16–31.
Morley JE, Cao L. Rapid screening for sarcopenia: Editorial. J Cachexia Sarcopenia Muscle, 2015;6(4):312–314. doi:https://doi.org/10.1002/jcsm.12079.
Tosato M, Marzetti E, Cesari M, et al. Measurement of muscle mass in sarcopenia: from imaging to biochemical markers. Aging Clin Exp Res, 2017;29(1):19–27. doi:https://doi.org/10.1007/s40520-016-0717-0.
Heymsfield SB, Stanley A, Pietrobelli A, Heo M. Simple Skeletal Muscle Mass Estimation Formulas: What We Can Learn From Them. Front Endocrinol. 2020;11:31. doi:https://doi.org/10.3389/fendo.2020.00031.
Tanaka T, Takahashi K, Akishita M, Tsuji T, Iijima K. Yubi-wakka” (finger-ring) test: A practical self-screening method for sarcopenia, and a predictor of disability and mortality among Japanese community-dwelling older adults. Geriatr Gerontol Int, 2017;18(2):224–232. doi:https://doi.org/10.1111/ggi.13163.
Roberts H, Denison H, Martin H, et al. A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. Age Ageing, 2011;40(4):423–429.
Beaudart C, Rolland Y, Cruz-Jentoft AJ, et al. Assessment of Muscle Function and Physical Performance in Daily Clinical Practice: A position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Calcif Tissue Int. April 2019. doi:https://doi.org/10.1007/s00223-019-00545-w.
Buckinx F, Croisier J, Reginster J, et al. Reliability of muscle strength measures obtained with a hand-held dynamometer in an elderly population. Clin Physiol Funct Imaging, 2017;37(3):332–340. doi:https://doi.org/10.1111/cpf.12300.
Damanti S, Azzolino D, Roncaglione C, Arosio B, Rossi P, Cesari M. Efficacy of Nutritional Interventions as Stand-Alone or Synergistic Treatments with Exercise for the Management of Sarcopenia. Nutrients, 2019;11(9):1991. doi:https://doi.org/10.3390/nu11091991.
Pedersen AN, Cederholm T. Health effects of protein intake in healthy elderly populations: a systematic literature review. Food Nutr Res, 2014;58(1):23364. doi:https://doi.org/10.3402/fnr.v58.23364.
Pahor M, Guralnik J, Ambrosius W, et al. Effect of Structured Physical Activity on Prevention of Major Mobility Disability in Older Adults: The LIFE Study Randomized Clinical Trial. JAMA, 2014;311(23):2387–2396. doi:https://doi.org/10.1001/jama.2014.5616.
Izquierdo M. [Multicomponent physical exercise program: Vivifrail]. Nutr Hosp. 2019;36(Spec No2):50–56. doi:https://doi.org/10.20960/nh.02680.
Casas-Herrero A, Anton-Rodrigo I, Zambom-Ferraresi F, et al. Effect of a multicomponent exercise programme (VIVIFRAIL) on functional capacity in frail community elders with cognitive decline: study protocol for a randomized multicentre control trial. Trials, 2019;20(1):362. doi:https://doi.org/10.1186/s13063-019-3426-0.
Marzetti E, Cesari M, Calvani R, et al. The “Sarcopenia and Physical fRailty IN older people: multi-componenT Treatment strategies” (SPRINTT) randomized controlled trial: Case finding, screening and characteristics of eligible participants. Exp Gerontol. 2018;113:48–57. doi:https://doi.org/10.1016/j.exger.2018.09.017.
Marzetti E, Calvani R, Landi F, et al. Innovative Medicines Initiative: The SPRINTT Project. J Frailty Aging. 2015;4:207–208.
Lardiés-Sánchez B, Sanz-París A, Pérez-Nogueras J, Serrano-Oliver A, Torres-Anoro ME, Cruz-Jentoft AJ. Influence of nutritional status in the diagnosis of sarcopenia in nursing home residents. Nutrition. 2017;41:51–57. doi:https://doi.org/10.1016/j.nut.2017.03.002.
Cederholm T, Jensen GL, Correia MITD, et al. GLIM criteria for the diagnosis of malnutrition — A consensus report from the global clinical nutrition community. Clin Nutr, 2019;38(1):1–9. doi:https://doi.org/10.1016/j.clnu.2018.08.002.
Cederholm T, Barazzoni R, Austin P, et al. ESPEN guidelines on definitions and terminology of clinical nutrition. Clin Nutr, 2017;36(1):49–64. doi:https://doi.org/10.1016/j.clnu.2016.09.004.
Phelan EA, Williams B, Snyder SJ, Fitts SS, LoGerfo JP. A five state dissemination of a communitybased disability prevention program for older adults. Clin Interv Aging, 2006;1(3):267–274. doi:https://doi.org/10.2147/ciia.2006.1.3.267.
The “Geriatric Frailty Clinic (G.F.C) for Assessment of Frailty and Prevention of disability” Team, Tavassoli N, Guyonnet S, et al. Description of 1,108 older patients referred by their physician to the “Geriatric Frailty Clinic (G.F.C) for assessment of frailty and prevention of disability” at the gerontopole. J Nutr Health Aging, 2014;18(5):457–464. doi:https://doi.org/10.1007/s12603-014-0462-z.
Deutz N, Bauer J, Barazzoni R, et al. Protein intake and exercise for optimal muscle function with aging: Recommendations from the ESPEN Expert Group. Clin Nutr, 2014;33(6):929–936. doi:https://doi.org/10.1016/j.clnu.2014.04.007.
Bauer J, Biolo G, Cederholm T, et al. Evidence-Based Recommendations for Optimal Dietary Protein Intake in Older People: A Position Paper From the PROT-AGE Study Group. J Am Med Dir Assoc, 2013;14(8):542–559. doi:https://doi.org/10.1016/j.jamda.2013.05.021.
McDonald CK, Ankarfeldt MZ, Capra S, Bauer J, Raymond K, Heitmann BL. Lean body mass change over 6 years is associated with dietary leucine intake in an older Danish population. Br J Nutr, 2016;115(9):1556–1562. doi:https://doi.org/10.1017/S0007114516000611.
Muir S, Montero-Odasso M. Effect of vitamin d supplementation on muscle strength, gait and balance in older adults: a systematic review and meta-analysis. J Am Geriatr Soc, 2011;59(12):2291–2300. doi:https://doi.org/10.1111/j.1532-5415.2011.03733.x.
Beaudart C, Buckinx F, Rabenda V, et al. The Effects of Vitamin D on Skeletal Muscle Strength, Muscle Mass, and Muscle Power: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Clin Endocrinol Metab, 2014;99(11):4336–4345. doi:https://doi.org/10.1210/jc.2014-1742.
Rooks D, Praestgaard J, Hariry S, et al. Treatment of Sarcopenia with Bimagrumab: Results from a Phase II, Randomized, Controlled, Proof-of-Concept Study. J Am Geriatr Soc, 2017;65(9):1988–1995. doi:https://doi.org/10.1111/jgs.14927.
Davidsen PK, Gallagher IJ, Hartman JW, et al. High responders to resistance exercise training demonstrate differential regulation of skeletal muscle microRNA expression. J Appl Physiol, 2011;110(2):309–317. doi:https://doi.org/10.1152/japplphysiol.00901.2010.
Hudelmaier M, Wirth W, Himmer M, Ring-Dimitriou S, Sänger A, Eckstein F. Effect of exercise intervention on thigh muscle volume and anatomical cross-sectional areas-quantitative assessment using MRI. Magn Reson Med, 2010;64(6):1713–1720.
Durheim MT, Slentz CA, Bateman LA, Mabe SK, Kraus WE. Relationships between exercise-induced reductions in thigh intermuscular adipose tissue, changes in lipoprotein particle size, and visceral adiposity. Am J Physiol-Endocrinol Metab, 2008;295(2):E407–E412. doi:https://doi.org/10.1152/ajpendo.90397.2008.
Ebner N, Steinbeck L, Doehner W, Anker S, von Haehling S. Highlights from the 7th Cachexia Conference: muscle wasting pathophysiological detection and novel treatment strategies. J Cachexia Sarcopenia Muscle, 2014;5(1):27–34.
Cruz-Jentoft A, Baeyens J, Bauer J, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing, 2010;39(4):412–423. doi:https://doi.org/10.1093/ageing/afq034.
Fielding R, Vellas B, Evans W, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc, 2011;12(4):249–256. doi:https://doi.org/10.1016/j.jamda.2011.01.003.
Morley J, Abbatecola A, Argiles J, et al. Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc, 2011;12(6):403–409. doi:https://doi.org/10.1016/j.jamda.2011.04.014.
Studenski S, Peters K, Alley D, et al. The FNIH Sarcopenia Project: Rationale, Study Description, Conference Recommendations, and Final Estimates. J Gerontol Ser A, 2014;69(5):547–558. doi:https://doi.org/10.1093/gerona/glu010.
Author information
Authors and Affiliations
Corresponding author
Additional information
Conflicts of Interest
Matteo Cesari received honoraria from Nestlé for presentations at scientific meetings and as member of scientific advisory boards. No other conflict of interest declared by the Authors.
Rights and permissions
About this article
Cite this article
Crosignani, S., Sedini, C., Calvani, R. et al. Sarcopenia in Primary Care: Screening, Diagnosis, Management. J Frailty Aging 10, 226–232 (2021). https://doi.org/10.14283/jfa.2020.63
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.14283/jfa.2020.63